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Abstract 16 
Complex biological tissues are highly viscoelastic and dynamic. Efforts to repair or replace cartilage, 17 
tendon, muscle, and vasculature using materials that facilitate repair and regeneration have been 18 
ongoing for decades. However, materials that possess the mechanical, chemical and resorption 19 
characteristics necessary to recapitulate these tissues have been difficult to mimic using synthetic 20 
resorbable biomaterials. Herein, we report a series of resorbable elastomer-like materials that are 21 
compositionally identical and possess varying ratios of cis:trans double bonds in the backbone. 22 
These features afford concomitant control over the mechanical and surface eroding degradation 23 
properties of these materials. We show the materials can be functionalized post-polymerization with 24 
bioactive species and enhance cell adhesion. Furthermore, an in vivo rat model demonstrates that 25 
degradation and resorption are dependent on succinate stoichiometry in the elastomers and the 26 
results show limited inflammation highlighting their potential for use in soft tissue regeneration and 27 
drug delivery. 28 
Introduction 29 
 30 
 Biological tissues are highly viscoelastic and dynamic.1,2 These qualities are lacking in 31 
synthetic degradable materials that are routinely available and applied to regenerative medicine.3 32 
Many of the biomaterials that have been used widely for regenerative medicine, such as poly(L-lactic 33 
acid) (PLLA) and poly(ε-caprolactone) (PCL), are semi-crystalline and do not replicate the elastic 34 
properties of native tissues. These materials also exhibit anisotropic degradation as a consequence 35 
of the presence of both amorphous and crystalline domains which leads to limited control over the 36 
resorption timelines.2-4 Attempts to engineer elastomeric materials with mechanical properties similar 37 
to native tissues have been focused on non-degradable systems.5,6 While these have been directed 38 
towards obtaining materials that possess the elastic properties of natural rubber, they have not 39 
followed its design principles, namely the incorporation of cis-1,4 alkene segments, to control the 40 
mechanical properties. While synthetic surrogates such as cis-1,4-polyisoprene, cis-1,4-41 
polybutadiene and analogues are available, each of these materials lack degradable units that 42 
facilitate resorption and lack the physical chemical or topological properties necessary to recapitulate 43 
a wide variety of tissues.2,7 In addition, anionic or metallocene-based polymerization synthesis 44 
methodologies are functional group intolerant making the incorporation of bioactive groups pre- or 45 
post-polymerization that facilitate specific cellular interactions challenging. 46 
Significant efforts have been expended to investigate degradable thermoplastic elastomers 47 
for biomaterials applications.8-23 However, nearly all elastomer-like materials developed for tissue 48 
engineering to date require crosslinking or blending to achieve desirable mechanical and 49 
degradation properties.2 Polyurethanes can be modified to control degradation by altering the hard 50 
segments, soft segments, and chain extenders to include varied amounts of hydrolytically 51 
degradable esters, orthoesters, amides, anhydrides, or enzymatically degradable units such as 52 
elastase-sensitive amino-acid chains.13 The materials are known to degrade heterogeneously on 53 
account of anisotropic degradation within the soft block-forming component that leaves non-54 
degraded hard block (typically urethane-based) components and results in exponential decreases in 55 
mechanical properties.24 Beyond this, the resultant degradation byproducts are acidic and often elicit 56 
a strong inflammatory response.2,13,24,25 To overcome the lack of hard block degradation, poly(ester 57 
urethane) ureas (PEUUs), which contain biodegradable urea linkages, have also been 58 
investigated.12 These materials however largely retain bulk erosion profiles and like polyurethanes, 59 
the hard-soft block ratio dictates both the mechanical and degradative properties in a manner that 60 
cannot be decoupled.10 Chemically crosslinked polymers like poly(glycerol sebacate) (PGS) and 61 
similar derivatives are capable of achieving elastic properties that mimic several soft tissues, and 62 
can achieve varied degradation rates by altering the crosslink density during preparation, but these 63 
materials are difficult to synthesize reproducibly, cannot be thermally processed after crosslinking, 64 
and are known to degrade too rapidly for long-term regeneration strategies (around 6 weeks in 65 
vivo).13,17,26-28  66 
The need to change the chemical structure to vary the mechanical properties presents the 67 
central dogma in these materials that has made it difficult to decouple the effects of chemistry and 68 
mechanical properties on degradability and tissue regeneration. Until now, no synthetic resorbable 69 
elastomer or elastomer-like polymer system have afforded independent control of mechanical 70 
properties and degradation de novo.2 We recently reported the first metal-free, stereocontrolled step-71 
growth polymerization via a nucleophilic thiol-yne addition which yielded a series of thermally-72 
processable elastomers in which the mechanical properties were controlled by the double bond 73 
stereochemistry.5,29  The double bond stereochemistry (% cis) in each thiol-yne step growth polymer 74 
was tuned based on solvent polarity and organic base which is able to preferentially directs the thiol 75 
addition to the cis stereochemistry. Truong et al. have shown that low and high % cis can be 76 
achieved by changing the base from Et3N (pKa=10.75) to DBU (pKa=13.5) while maintaining the 77 
solvent (CDCl3). However, moderately high % cis subunits can be achieved with Et3N base when a 78 
more polar solvent such as DMSO is used. All high % cis polymers were formed using DBU/CHCl3 79 
but lower % cis contents were formed by using Et3N and varying compositions of DMF and CHCl3 80 
(17:3, 7:3, and 100% DMF).  However, in this initial report, the materials were non-degradable and 81 
display no significant mass loss over one year in 5 M KOH(aq) solution, most likely a result of 82 
resistance to ester hydrolysis due to conjugation.  83 
In order to translate these elastomer-like systems into regenerative medicine applications, a 84 
new series of polymers have been developed that incorporates degradable succinate-based 85 
monomer units (Figure 1A). By altering the stoichiometry of succinate incorporation, the degradation 86 
rate of the material can be tuned precisely while retaining control over the mechanical properties by 87 
maintaining the cis/trans stereochemistry of the double bond (Figure 1B). This structural control 88 
enables the independent tuning of mechanical and degradative properties and thus overcomes a 89 
major hurdle in biomaterials. Furthermore, as a consequence of the highly hydrophobic nature of the 90 
material, they likely exhibit surface erosion behavior (Figure 3B). In turn, these materials display 91 
excellent in vitro cell viability and have been implanted in vivo to assess degradation and the 92 
inflammatory response over 4 months in a subcutaneous rat model.  93 
 94 
Results and Discussion 95 
 Succinic acid is found naturally within the body and can be metabolized by the Krebs cycle.30 As 96 
such, it provided the ideal building block from which to introduce non-conjugated esters into the 97 
elastomer structure with which to influence biodegradation rates. Creation of a series of materials 98 
using a nucleophilic thiol-yne polymerization methodology was undertaken to target high cis- content 99 
at comparable molar mass (Mw = 100 - 150 kDa) using propane-1,3-diyl dipropiolate (C3A, 1) in 100 
combination with equimolar dithiols composed from mixtures of 1,6-hexanedithiol (C6S) and the 101 
succinate-derived dithiol monomer bis(3-mercaptopropyl) succinate (2) (Table 1). 102 




 The ability to significantly influence mechanical properties by simply altering the cis:trans ratio by 107 
judicious choice of polymerization catalyst and solvent enables the manipulation of the materials’ 108 
mechanical properties without changing the fundamental composition of the copolymer and thus 109 
affecting its degradation behavior. In order to demonstrate this, a series of materials were 110 
synthesized at constant ratio of C6s and succinate-based monomer, 2, (9%) while varying the 111 
cis:trans ratio between 62 and 80% which represents more than an order of magnitude change in 112 
elastic modulus of the material. The stoichiometric ratio of 2:3 and the %cis is determined easily 113 
from the splitting of the vinyl proton doublets at δ = 5.7 and 7.7 ppm (trans, 15 Hz) and δ = 5.8 and 114 
7.1 ppm (cis, 9 Hz), respectively, in the 1H NMR spectra of the polymers in solution (Figure 1B). 115 
 116 
 Uniaxial tensile testing revealed that increasing the incorporation of the succinate-based 117 
monomer 2 led to decreased ultimate tensile strength and Young’s modulus and increased 118 
elongation at break (Figure 2B, Table 2). This behavior is consistent with a more elastic material that 119 
is expected from the interruption of crystallinity through the introduction of ester groups into the main 120 
chain that disrupt chain packing and increase chain mobility. These findings were confirmed via 121 
differential scanning calorimetry (DSC) which showed that increasing %cis without altered succinate 122 
content increased the glass transition temperature in line with results from our previous work.5,29 123 
Significantly, the materials exhibit high thermal stability and the onset of degradation temperatures 124 
exceeds 350 °C. These traits are critical for thermal processing and fabrication.  125 
 126 
 An in vitro investigation of the hydrolytic swelling and degradation behavior showed the polymers 127 
to be chemically stable with no visible degradation in PBS at ambient temperature over a 1-month 128 
period (Figure 3). In order to accelerate the hydrolytic degradation process, the samples were 129 
incubated in 5 M KOH (aq) solution at ambient temperature. The data show that the materials with 130 
increased succinate-based monomer, 2, yielded faster rates of degradation. Importantly, the mass 131 
loss profiles are nearly linear in nature and show no evidence of accelerated degradation as a result 132 
of acidosis and swelling via bulk erosion. The dimensions of the materials were noted to decrease 133 
concomitantly with time which is highly indicative of a surface erosion mechanism. SEM analysis of 134 
test substrates (Figure 3B) exposed to accelerated degradation conditions indicates uniform 135 
degradation and pitting that confirms surface erosion as the most prevalent degradation process. 136 
Taken together, these observations demonstrate that, unlike any other degradable biomaterials, the 137 
mechanical and degradation properties of these elastomer-like polymers can be controlled 138 
independently. This is a distinct difference from known polyesters.  To demonstrate the potential, by 139 
careful control over double bond stereochemistry and succinate monomer (2) content, we prepared 140 
materials that displayed comparable degradation rates but markedly different mechanical properties 141 
and vice versa (comparable mechanical properties with markedly different degradation rates – 142 
(Figure 2A&B).  The control over each of these properties will be critical to future applications where 143 
designers will need to engineer subtle changes without returning to new synthetic methods. 144 
 145 
To investigate the potential for use in biomaterial applications, cell viability, spreading and 146 
proliferation assays were used as an initial method to determine the cellular responses to the 147 
elastomer-like polymers. Human mesenchymal stem cells (hMSCs) and MC3T3 cells were cultured 148 
on glass slides spin-coated with each material variant or on the control polymer, poly(L-lactide), 149 
PLLA. Cell viability was found to be higher than 95% on all samples using a Live/Dead® assay. Cell 150 
adhesion and spreading was assessed by staining F-actin, vinculin-labeled focal adhesion contacts, 151 
and cell nuclei and revealed that the hMSCs adopted an elongated and spindle-like shape on all 152 
samples. Cell proliferation was measured with a PrestoBlue® metabolic assay, after 24 h, 3 days 153 
and 7 days of incubation. After 7 days the population of cells on each sample increased 154 
approximately 5 times the original concentration (Supplemental Figure 23). 155 
 One of the key aspects of a translationally relevant material is the ability to control the placement 156 
and concentration of functional species (drug, peptide, protein) on the surface of a materials where 157 
the group is bioavailable to the surrounding cells and tissues.31  While many methods are available 158 
for peptide polymer conjugation, we designed a dialkyne monomer, but-2-yne-1,4-diyl dipropiolate 159 
(3) that possesses an internal triple bond. As a consequence of the increased distance from the 160 
electron withdrawing groups, the reactivity of internal alkynes is distinctly different than terminal 161 
alkynes. The internal alkynes were found to be stable during the nucleophilic thiol-yne addition 162 
polymerization process with C3A (1) and C6S (1,6-hexane dithiol) as comonomers which left it 163 
available for selective post-polymerization functionalization of the resulting materials (Figure 4E). 164 
Following the polymerization and a film casting process, a Megastokes®-673-azide dye surrogate 165 
(Figure 4F) was covalently tethered to the internal alkyne functionalized poly(bis(4-166 
(propioloyloxy)but-2-yn-1-yl)-3,3'-(hexane-1,6-diylbis(sulfanediyl))) using Cp*RuCl(COD) as a 167 
catalyst.32 After washing, the film remained fluorescent thus evidencing the conjugation of the dye to 168 
the polymer. To extend the concept and show utility from a biomaterials viewpoint, we also used this 169 
methodology to attach an azide-functionalized GRGDS peptide to the films. While only an initial 170 
demonstration, the presence of the adhesion peptide had a distinct influence on the cell adhesion 171 
and spreading properties (Figure 4G and 4H). Following peptide conjugation, increased cell 172 
adhesion, spreading and integrin-associated actin fiber formation was evident in the RGD 173 
derivatized films relative to the unfunctionalized films. Future studies are developing this technique 174 
to apply other bioactive groups designed to influence specific cellular activities. 175 
 176 
  177 
 178 
 The lack of cytotoxicity and enhanced cellular activity confirmed that the thiol-yne 179 
stereoelastomer materials could be implanted in vivo for tissue compatibility studies.  Elastomeric 180 
discs possessing various cis content and succinate stoichiometry were implanted subcutaneously for 181 
4 months to observe the degradation behavior and tissue inflammatory responses in vivo. 182 
Significantly, no gross inflammation, which would appear as a dense calcified capsule, was evident 183 
from macroscopic images of the samples taken at each timepoint (Figure 5B). Sections stained with 184 
hematoxylin and eosin (H&E) were analyzed for inflammatory responses in the form of fibrous 185 
capsule formation. Sections stained with H&E were also assessed for inflammatory cell infiltration. 186 
Fibrous encapsulation occurred as expected, and the granuloma grew thicker over 4 months of 187 
incubation with no significant difference compared to PLLA (Figure 5). The granuloma was less than 188 
200 μm thick for all samples, which has previously been reported as acceptable in terms of tissue 189 
compatibility for long-term implants.4,33,34 This is indicative of the tunable degradation profiles from 190 
varied succinate content as increasing implant degradation rates correlates with greater cellular 191 
remodeling processes.34   192 
 193 
H&E slides were quantitatively analyzed for neutrophils, lymphocytes, plasma cells, single 194 
macrophages, multinucleated giant cells, and necrosis at the 1, 2, and 4-month time points following 195 
a subcutaneous rat implant model. Additionally, each slide was assessed for inflammatory cell 196 
infiltrate based on a modified scoring system outlined by the International Organization for 197 
Standardization (ISO 10993-6 Annex E) by a board-certified veterinary pathologist. The numbers of 198 
inflammatory cells were estimated in a 400× field using light microscopy images, and a score was 199 
assigned for each inflammatory cell type as denoted in Table 3. The most severely affected region of 200 
the evaluated tissue was utilized to assign a score. The severity of necrosis was judged by the 201 
percentage of the fibrous capsule exhibiting evidence of necrosis (pyknosis, karyorrhexis, or 202 
karyolysis) not including any inflammatory cell infiltrate. Comparisons were made between 203 
elastomers with the 80%cis content and containing a range of %succinate content (Figure 2). A 204 
striking difference was apparent between elastomers with lower succinate content from 10-50% 205 
compared to the 100% succinate-containing elastomer after only one month, and increasingly over 4 206 
months (Table 2).  207 
Full tissue infiltration into the polymer space occurred as the 80% cis / 100% succinate polymer 208 
degraded (Figure 5). This was noted by an increase in the total number of inflammatory cells into the 209 
capsule space with a total score of 8.6 ± 1.5, 9.1 ± 1.2, and 10.9 ± 1.9 for 1, 2, and 4-months 210 
respectively. This was noticeably greater than all other materials which elicited total scores ranging 211 
between 4.3 ± 1.2 – 4.9 ± 1.8, 3.8 ± 1.4 - 4.7 ± 1.7, and 2.6 ± 1.3 – 4.0 ± 2.0 for 1, 2, and 4-months 212 
respectively. For reference, medical-grade polypropylene has scored around 7.5 in a similar recent 213 
study.34 While used widely in the clinic, this value would be noted as a persistent low level 214 
inflammatory response. In each of the materials above, the reported values are 30-50% less than 215 
polypropylene. The investigation of these materials in more translationally relevant applications is 216 
ongoing. 217 
 Very few multinucleated giant cells were found surrounding the implants and there was no 218 
evidence of necrosis, even at extended timepoints. The only samples with a few multinucleated giant 219 
cells were the 80% cis / 50% succinate and 80% cis / 100% succinate elastomers, where giant cells 220 
were found infiltrating degraded polymer areas. Multinucleated giant cells attempt to encapsulate 221 
portions of the foreign body that have broken away as well as releasing factors that degrade 222 
extracellular matrix and cause damage and degradation of the implanted material, and thus are 223 
regarded as an obstacle for clinical translation of biomaterials.35,36 The absence of multinucleated 224 
giant cells shows a limited foreign body response over the period of the experiment. Macrophage 225 
staining of 4 month 80c100s polymer shows evidence of a robust inflammatory response that is 226 
expected to occur during the degradation, resorption and remodeling process. CD68 was used as a 227 
pan-macrophage (M0, blue) marker, CCR7 was used to indicate classically activated macrophages 228 
(M1, red), and CD206 was used to indicate the presence of alternatively activated macrophages 229 
(M2, green). Non-specific control staining shows subtle autofluorescence of the stereoelastomers 230 
inhibits quantitative analysis of macrophage presence.  The presence of M2 macrophages indicates 231 
that a transition to a remodeling phase is likely occurring.37  Trichrome staining shows no evidence 232 
of capsule formation in the stereoelastomer samples while a thicker layer of collagen deposition 233 
surrounds the PLLA implant.  The semi-crystalline PLLA control material in this study is likely not 234 
degrading quickly compared to previous literature reports of amorphous PDLLA where 235 
multinucleated giant cell numbers were extremely high.3837 The surface chemistry differences 236 
imparted by the crystalline domains of the materials play an important role in the amount and 237 
conformation of protein absorption, and this subsequently affects the process of multinucleated giant 238 
cell formation.  239 
Picrosirius red (PSR) staining is a commonly used histological technique to visualize collagen in 240 
paraffin-embedded tissue sections.39 PSR stained collagen appears red in optical microscopy. 241 
However, it is largely unknown that PSR stained collagen also shows a red fluorescence, whereas 242 
live cells have a distinct green autofluorescence. As shown in Figure 6, Picrosirius Red staining is 243 
present at the edge of the degrading stereoelastomers (1 month) and throughout the site formerly 244 
occupied by the degraded 80cis100suc materials after 4 months of subcutaneous incubation. This 245 
clearly shows that collagen deposition and maturation occurred throughout the space formerly 246 
occupied by the polymer.  247 
 248 
 These results, along with a decrease in size of the 80% cis / 100% succinate, shows that tissue 249 
remodeling and near complete polymer resorption occurs over a 4-month time frame (Figure 5). 250 
Remodeling of the degraded polymer over 4 months is comparable to that seen in poly(glycerol 251 
succinate) materials after 9 weeks of implantation, suggesting that this material is suitable for tissue 252 
regeneration, particularly for situations where the polymer must endure beyond 2 months to provide 253 
appropriate mechanical load reinforcement.40 Future studies for these materials will observe the 254 
effects of degradation and associated inflammation for the slower degrading variants. Many recent 255 
findings have noted the importance of fine-tuning degradation rates to match regeneration rates for 256 
optimal tissue growth and mechanical reinforcement as needed throughout healing.2,24,29,41 257 
Significantly, this study has shown significant tissue growth into non-functionalized bulk implants 258 
where inflammation and granuloma formation was limited. The versatility in the synthesis of these 259 
elastomer-like polymers with controlled variability of mechanical properties and degradation rates 260 
marks significant progress in the field of degradable biomaterials.  261 
 In summary, we have developed a series of highly tunable and resorbable elastomer-like 262 
polymers that afford concomitant control of mechanical and degradation properties. These materials 263 
have shown excellent cellular responses in vitro and possess limited inflammatory responses in vivo. 264 
Most importantly, the variants containing 100% succinate incorporation were capable of degrading in 265 
vivo over a period of four months and were replaced with mature and developing tissues. These 266 
responses show that these materials are non-toxic and further, will provide a new developmental 267 
platform for regeneration of tissues with varied mechanical and degradation requirements. Future 268 
studies on these materials will include optimization of material properties, control/inhibition of 269 
crosslinking, post-polymerization functionalization with bioactive species and assessment of 270 
mechanical properties throughout degradation. 271 
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 281 
Methods 282 
Materials: The following chemicals were used as received: acetone (Sigma-Aldrich, ≥ 99.0%), 283 
chloroform (CHCl3: VWR Chemicals, 99%), d-chloroform (CDCl3: Apollo, > 99%), 1,8-284 
diazabicyclo[5.4.0]undec-7-ene (DBU: Sigma-Aldrich, 98%), diethyl ether (Et2O: Sigma-Aldrich, ≥ 285 
99.8%), N,N dimethylformamide (DMF: Fisher Scientific, LR grade), 2,6-di-tert-butyl-4-methylphenol 286 
(BHT: Alfa Aesar, 99%), ethyl acetate (EtOAc: Fisher Scientific, LR grade), hexane (Hex: VWR 287 
Chemicals, 99%), magnesium sulfate (MgSO4: anhydrous, Fisher Scientific, LR grade), 3-mercapto-288 
1-propanol (Tokyo Chemical Industry Ltd. UK, 96%), 1,3-propanediol (Sigma-Aldrich, 98%), propiolic 289 
acid (Acros Organics, 98%), silica gel (SiO2: Apollo Scientific, 40-63 micron), sodium chloride (NaCl: 290 
Fisher Scientific, > 99%), sodium hydrogen carbonate (NaHCO3: Fisher Scientific, > 99%), sulfuric 291 
acid (Fisher Scientific, > 95%),  triethylamine (Et3N: Fisher Scientific, LR grade).  1,6-hexanedithiol 292 
(Sigma-Aldrich, ≥ 97%) was vacuum distilled prior to use and stored in Young’s tapped ampuoles 293 
under N2.  Poly(L-lactic acid) (PLLA) (Ingeo™ Biopolymer 3100HP) was ordered from NatureWorks. 294 
 295 
Molecular Structure and Thermal Characterization 296 
 Size exclusion chromatography (SEC) analyses were performed on a system composed of a 297 
Varian 390-LC-Multi detector using a Varian Polymer Laboratories guard column (PLGel 5 μM, 50 × 298 
7.5 mm), two mixed D Varian Polymer Laboratories columns (PLGel 5μM, 300 × 7.5 mm) and a 299 
PLAST RT autosampler. Detection was conducted using a differential refractive index (RI) detector.  300 
The analyses were performed in CHCl3 at 40 °C and containing 0.5% w/w Et3N at a flow rate of 1.0 301 
mL/min. Linear polystyrene (PS) (162 – 2.4 × 105 g.mol-1) standards were used to calibrate the 302 
system. EcoSEC HLC-8320 GPC (Tosoh Bioscience LLC, King of Prussia, PA) equipped with a 303 
TSKgel GMHHR-M mixed bed column and refractive index (RI) detector was performed to analyze 304 
poly(bis(4-(propioloyloxy)but-2-yn-1-yl)-3,3'-(hexane-1,6-diylbis(sulfanediyl))) (10). Molecular mass 305 
was calculated using a calibration curve determined from polystyrene standards (PStQuick MP-M 306 
standards, Tosoh Bioscience, LLC) with DMF with 0.1 M LiBr as eluent flowing at 1.0 mL·min-1 at 307 
323K, and a sample concentration of 3 mg·mL-1 308 
 Nuclear magnetic resonance (1H, 13C) spectra were recorded in CDCl3 on a Bruker DPX-400 309 
spectrometer at 298 K. Chemical shifts are reported as δ in parts per million (ppm) and referenced to 310 
the chemical shift of the residual solvent resonances (CDCl3 
1H: δ = 7.26 ppm, 13C: δ = 77.16 ppm). 311 
The resonance multiplicities are described as s (singlet), d (doublet), t (triplet), q (quartet) or m 312 
(multiplet). 313 
 Thermogravimetric analysis (TGA) (Q500, TA Instruments, New Castle, DE) was performed over 314 
a temperature range from 0 to 600 °C at a heating rate of 10 °C/min. A 5% loss in mass was used to 315 
determine the onset temperature of degradation (Td).  316 
 Differential scanning calorimetry (DSC) (Q2000, TA Instruments, New Castle, DE) was used with 317 
a temperature range from -20 to 200 °C and a scanning rate of 10 °C/min in a 318 
heating/cooling/heating mode to determine glass transition temperatures (Tg) of polymers obtained 319 
during the second heating cycle. 320 
 321 
Monomer Synthesis  322 
Propane-1,3-diyl dipropiolate (C3A, 1): 1,3-propanediol (20.00 g, 0.263 mol) was added to a 1 L 323 
single neck round bottom flask. To this was added toluene (100 mL) and benzene (100 mL). Two 324 
drops of H2SO4 were added and the solution was allowed to stir at room temperature for 5 min 325 
before adding propiolic acid (50.00 g, 0.714 mol). A Dean-Stark apparatus with condenser was fitted 326 
and the reaction was then refluxed for 16 h at 120 °C or until the required amount of water was 327 
collected. The solution was then cooled to room temperature and solvent extracted with saturated 328 
NaHCO3 solution (2 x 200 mL) to remove any residual acids. The organic phase was then collected, 329 
dried over MgSO4, filtered and reduced in volume to dryness. The product was then purified on silica 330 
gel isocratically using 4:1 hexane/EtOAc and collecting the 1st fraction. After removal of the solvent, 331 
the final product was further purified by distillation under high vacuum at 160 °C to yield colorless oil 332 
that slightly crystallised on sitting (24.63 g, 52% yield). Rf (3:2 Hex/EtOAc) = 0.43; Melting point: 25 333 
°C; 1H NMR (500 MHz, CDCl3) δ 4.30 (t, 
3JHH = 6.2 Hz, 4H), 2.88 (s, 2H), 2.19 – 1.96 (m, 2H); 
13C 334 
NMR (125 MHz, CDCl3) δ 152.6, 75.3, 74.5, 62.6, 27.5; ESI-MS Calcd for C9H8O4Na (M+Na): 203.0, 335 
Found: 203.0; Anal Calcd for C9H8O4: C 60.00; H 4.48 %. Found: C 59.70; H 4.41 %. 336 
 337 
Bis(3-mercaptopropyl) succinate (2): 3-mercaptopropanol (7.30 g, 0.079 mol) was added to a 250 338 
mL single neck round bottom flask. To this was added toluene (60 mL) and benzene (60 mL). Two 339 
drops of H2SO4 were added and the solution was allowed to stir at room temperature for 5 min 340 
before adding succinic acid (4.40 g, 0.037 mol). A Dean-Stark apparatus with condenser was fitted 341 
and the reaction was then refluxed for 16 h at 120 °C or until the required amount of water was 342 
collected. The solution was then cooled to room temperature and solvent removed by vacuum 343 
transfer. The product was resolubilized in CHCl3 (100 mL) and extracted with saturated NaHCO3 344 
solution (2 x 200 mL) to remove any residual acids. The organic phase was then collected, dried 345 
over MgSO4, filtered and reduced in volume to dryness. The product was then purified on silica gel 346 
isocratically using 3:2 hexane/EtOAc and collecting the 1st fraction. After removal of the solvent, the 347 
final product was further purified by distillation under high vacuum (0.15 Torr) at 220 °C to yield 348 
colorless oil (7.8 g, 79% yield). Rf (3:2 Hex/EtOAc) = 0.4; 
1H NMR (400 MHz, CDCl3) δ 4.21 (t, 
3JHH = 349 
6.2 Hz, 4H), 2.62 (s, 4H), 2.58 (q, 3JHH = 6.6 Hz, 4H), 1.40 (t, 
3JHH = 8.1 Hz, 2H); 
13C NMR (100 MHz, 350 
CDCl3) δ 172.3, 62.9, 32.9, 29.2, 21.2; ESI-MS Calcd for C10H18O4S2Na
+ (M+Na+): 289.1, Found: 351 
289.0; Anal Calcd for C10H18O4S2: C 45.09; H 6.81 %. Found: C 59.70; H 4.41 %. 352 
 353 
Sodium propiolate. Sodium propiolate was synthesized according to the procedure described by 354 
Bonnesen et al.1, Sodium hydroxide (0.645 g, 0.016 mol) was dissolved in methanol (50 mL) in a 355 
250 mL round-bottom flask and protected from light. The solution was cooled to 0 °C for 10 min.  356 
Then propionic acid (1.00 mL, 0.016 mol) was added with stirring. The solution was allowed to warm 357 
to ambient temperature and stirred for additional 2 h.  The solvent was then removed by rotary 358 
evaporation. A white solid product was formed and dried under high vacuum to yield 3 (1.44 g, 97%). 359 
The product should be stored in the dark due to light sensitivities. 1H NMR (300 MHz, CD3OD) δ 360 
2.95 (s, 1H). 13C NMR (75 MHz, CD3OD) δ 160.64, 81.83, 69.12. 361 
 362 
But-2-yne-1,4-diyl bis(4-methylbenzenesulfonate).  But-2-yne-1,4-diyl bis(4-methylbenzene 363 
sulfonate) was synthesized according to the procedure described by Maisonial et al.2  Briefly, p-364 
toluenesulfonyl chloride (24.00 g, 0.126 mol) and 1,4-butynediol (4.00 g, 0.046 mol) were dissolved 365 
in Et2O (300 mL). The mixture was cooled to -15 °C for 15 min before potassium hydroxide (16.00 g, 366 
0.285 mol) was added slowly. The resulting solution was stirred at 0 °C for 3 h and poured into ice 367 
water (300 mL).  When the solution reached ambient temperature, the solution was extracted with 368 
DCM (200 mL × 3) and the organic layer was collected, dried with anhydrous Na2SO4, filtered and 369 
concentrated. The solid was washed with Et2O (100 mL × 3) and dried under vacuum 24 h to yield 4 370 
(14.66 g, 80%) as a white solid. 1H NMR (300 MHz, CDCl3) δ 7.77 (d, J = 8.8 Hz, 4H), 7.34 (d, J = 371 
8.8 Hz, 4H), 4.58 (s, 4H), 2.46 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 145.54, 132.80, 130.01 (× 2), 372 
128.16 (× 2), 81.04, 57.21, 21.76.  373 
 374 
But-2-yne-1,4-diyl dipropiolate (3).  Under reduced light conditions, sodium propiolate (7.600 g, 375 
0.083 mol) and But-2-yne-1,4-diyl bis(4-methylbenzene sulfonate) (12.00 g, 0.030 mol) were 376 
dissolved in DMF (120 mL), and the mixture was heated to 50 °C, and allowed to stir for 24 h. After 377 
the reaction was cooled down to ambient temperature, a saturated solution of NH4Cl (200 mL) was 378 
added to the mixture and the reaction was stirred for 10 min. The mixture was extracted with DCM 379 
(150 mL × 3) and the organic extracts were combined, extracted with saturated solution of NaHCO3 380 
(150 mL× 3). The organic layer was combined and dried over anhydrous Na2SO4, filtered, and 381 
concentrated. The residue was purified by flash column chromatography on silica gel 382 
(EtOAc/hexanes 1:3; Rf = 0.30). After removal of the solvent, the final product was further purified by 383 
distillation under high vacuum at 110 °C to yield a colorless oil (3.76 g, 65%). 1H NMR (300 MHz, 384 
CDCl3) δ 4.81 (s, 4H), 2.97 (s, 2H). 
13C NMR (75 MHz, CDCl3) δ 151.78, 80.60, 76.34, 73.82, 53.28. 385 
ESI-MS for C10H6O4Na, m/z theoretical: [M+Na]
+ = 213.02 Da, observed: [M+Na]+ = 213.0 Da. 386 
 387 
General procedure for thiol-yne step growth polymerization.  An example of the thiol-yne step 388 
growth polymerization is as follows: 1,6-hexanedithiol (0.73 g, 4.9 x 10-3 mol) and 2 (0.32 g, 1.2 x 10-389 
3 mol) were added to a 20 mL scintillation vial. Propane-1,3-diyl dipropiolate (1.10 g, 6.1 x 10-3 mol) 390 
was added to the solution by quantitative transfer with CHCl3 (12 mL). The solution was then cooled 391 
to -15 °C with stirring for 15 min before DBU (9 µL, 6.0 x 10-5 mol) was added. The addition of DBU 392 
produced an exotherm causing the solvent to bubble. After 2 min of stirring, the reaction was then 393 
allowed to warm to room temperature and continued to stir, during which time the solution became 394 
very viscous. After 1 h, the solution was diluted with CHCl3 (8 mL). The polymer solution was then 395 
precipitated into 1:1 diethyl ether/acetone (200 mL) and collected by decanting the supernatant. The 396 
polymer was then redissolved in CHCl3 (20 mL) and reprecipitated into 1:1 diethyl ether/acetone 397 
(200 mL). The polymer was again redissolved in CHCl3 (20 mL) and 100 mg BHT (5 %w/w) was 398 
added. The final solution was then precipitated into n-hexane (200 mL), collected by decanting the 399 
supernatant, and dried in vacuo at room temperature for 24 h. SEC (CHCl3 + 0.5% Et3N) Mn = 35.2 400 
kDa, Mw = 110.8 kDa, Mp = 106.9 kDa, ÐM = 3.15. 
1H NMR (CDCl3, 400 MHz) % incorporation of 2 = 401 
18.7%; % cis = 79%. 402 
 403 
Variation of molecular mass. The molecular mass of the thiol-yne step growth polymers was 404 
varied by changing the amount of dithiol in relation to the dialkyne such that the dialkyne was always 405 
in excess. Monomer ratios were determined using the extended Carothers equation for one 406 
monomer in excess (assuming p → 100%).1 407 
 408 
Procedure of thiol-yne step-growth polymerization for but-2-yne-1,4-diyl dipropiolate. 1,6-409 
Hexanedithiol (4.300 g, 0.028 mol) was added into 500 mL round bottom flask and but-2-yne-1,4-diyl 410 
dipropiolate (5) (5.500 g, 0.029 mol) was added to a 500 mL round bottom flask with 200 mL CHCl3. 411 
The solution was then cooled to -15 °C with stirring for 20 min before DBU (44 μL, 29 mmol) was 412 
added in one portion. Notably, the addition of DBU caused the solvent to bubble due to an 413 
exothermic reaction. After stirring for 10 min, the reaction was allowed to warm to room temperature 414 
and continued to stir. After 1 h, a couple drops of but-2-yne-1,4-diyl dipropiolate 5 in CHCl3 (5 mL) 415 
was added into the reaction solution. After stirring for an additional 30 min, the solution was diluted 416 
with CHCl3 (50 mL) and BHT (0.48 g, 0.002 mol) before the precipitation steps. The polymer solution 417 
was then precipitated into diethyl ether (1.5 L) and collected by decanting the supernatant. The 418 
polymer was then redissolved in CHCl3 (150 mL) and reprecipitated into diethyl ether (1.5 L), 419 
collected by decanting the supernatant, and dried by high vacuum system at room temperature for 420 
24 h to give pale yellow polymer poly(bis(4-(propioloyloxy)but-2-yn-1-yl)-3,3'-(hexane-1,6-421 
diylbis(sulfanediyl))) (10) (8.3 g, 85%). SEC (DMF+0.1M LiBr, based on PS standards ) Mn = 24.7 422 
kDa, Mw = 35.4 kDa, ÐM = 1.46. 
1H NMR (CDCl3, 300 MHz) % cis: % trans = 78 %: 22 %. DSC: Tg = 423 
22 oC. TGA: Td = 287 
oC. 424 
 425 
Post-polymerization functionalization with GRGDS peptide.  The end-capped polymer 426 
poly(bis(4-(propioloyloxy)but-2-yn-1-yl) 3,3'-(hexane-1,6-diylbis(sulfanediyl))) (10) (300 mg; Mn = 427 
24.7 kDa, Mw = 35.4 kDa, ÐM = 1.46.) and Cp*RuCl(COD) (1 mg, 0.003 mmol) were added to a 100 428 
mL two neck round bottom flask and the round bottom flask was evacuated and purged with N2 three 429 
times before dried DMF (40 mL) was added.  Then, 3 wt% N3-GRGDS peptide (FW= 629.63 g/mol; 9 430 
mg) was dissolved in dried DMF (5 mL) and added into the reaction solution by syringe and allowed 431 
to stir for 12 h. The solution of GRGDS peptide functionalized polymer was precipitated into ethanol 432 
(500 mL), collected and dried under vacuum for 24 h to afford GRGDS peptide functionalized 433 
polymer poly(bis(4-(propioloyloxy)but-2-yn-1-yl)-3,3'-(hexane-1,6-diylbis(sulfanediyl)))-GRGDS. 434 
 435 
Mechanical Testing: Destructive tensile tests were performed to determine the effects of altered 436 
cis-alkene and succinate incorporation on Young’s Modulus (E) and ultimate strain (εU). Samples 437 
(n=3) were prepared using vacuum film compression (Technical Machine Products, Cleveland, OH) 438 
to press films measuring 50 mm x 50 mm x 0.5 mm. Polymer was preheated at 120 °C for 15 439 
minutes, and then compressed at 10,000 lbs of pressure for 4 minutes before cooling rapidly under 440 
vacuum. Tensile bars were cut using a custom-made dog bone shaped die cutter and were pulled at 441 
several rates to determine the rate at which equilibrium modulus of all samples could be obtained. 442 
Rates tested were 0.1, 1, 5, 10 and 20 mm/min. A rate of 10 mm/min was determined to be 443 
appropriate. Samples were tested in an Instron® (5567) equipped with a 100 N load cell. The results 444 
were recorded using Bluehill® 3 software (Instron®, Norwood, MA). The modulus values quoted are 445 
a from the tangent of the initial yield point at low strain where it exists or over the 2-10% strain 446 
regime.  The results are the average values of 5 (n=5) individual measurements for each material. 447 
 448 
Accelerated in vitro Degradation Studies: A film in 0.5 mm thickness of each elastomer was 449 
prepared from vacuum film compression using the same method as stated above. Discs with 4 mm 450 
in diameter were cut from the film and placed in 5 M NaOH solution in the incubator (37 C, 5% CO2 451 
humidified atmosphere) for up to 200 days. The films absorbed, swell, degraded and the 5 M NaOH 452 
solution was changed every week to ensure the degradation process. At specified intervals, the 453 
samples were removed, dried and weighed. The results of mass changes are the average values of 454 
four (n=4) individual samples for each material at each time point.  455 
 456 
Biological Reagents: Human mesenchymal stem cells (hMSCs) were ordered from Lonza and 457 
used at passage 4 following manufacturer protocols. Standard MC3T3 fibroblasts were obtained 458 
from Riken and used at passage 6 following manufacturer protocols. The following reagents were 459 
used as received for cell culture and assessment of cellular activity: α-MEM, penicillin (10,000 460 
U/mL)/streptomycin (10,000μg/mL) (pen/strep), fetal bovine serum (FBS), trypan blue, and the 461 
Live/Dead® assay kit were ordered from Life Technologies; trypsin-ethylene diamine tetraacetice 462 
acid (EDTA), Dulbecco’s phosphate buffered saline (PBS), 1,4-piperazinediethanesulfonic acid 463 
(PIPES), polyethylene glycol (PEG, 8000 kDa), paraformaldehyde, Triton™ X-100, sodium 464 
borohydride, donkey serum, and secondary donkey anti-mouse IgG-488 antibody were ordered from 465 
Fisher Scientific; ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), and 466 
mouse monoclonal primary anti-vinculin antibody were purchased from Sigma Aldrich; Rhodamine 467 
phalloidin was ordered from VWR; 4’,6-diamidino-2-phenylindole (DAPI) nuclear stain and the 468 
PrestoBlue® metabolic assay were ordered from Life Technologies Invitrogen™. 469 
 Ketamine HCl (KetaVed®, 100 mg/mL), Xylazine (AnaSed®, 20 mg/mL), Acepromazine Maleate 470 
(PromAce®, 10 mg/mL), Buprenorphine (Buprenex, 0.3mg/mL), sodium pentobarbital 471 
(Beuthanasia®-D); Povidone-iodine solution (Vetadine); Modified Masson’s Trichrome staining kit 472 
was ordered from Scytek Laboratories, Inc.; goat polyclonal primary anti-CD206 (C-20) antibody was 473 
ordered from SantaCruz Biotechnology; Mayer’s Hematoxylin, Eosin Y, mouse monoclonal primary 474 
anti-CD68/SR-D1 (KP1) antibody, rabbit monoclonal primary anti-CCR7 (Y59) antibody, Sodium 475 
Citrate Dihydrate, DPX Mountant, Trizma® base (Tris(hydroxymethyl)aminomethane) (Acros 476 
Organics, 99.85%), Sodium Chloride (NaCl, Acros Organics), and Tween® 20 (Polyethylene glycol 477 
sorbitan monolaurate, Acros Organics) were ordered from Fisher Scientific; VECTASHIELD HardSet 478 
Mounting Medium was ordered from Vector Laboratories; donkey anti-mouse Alexa Fluor® IgG-350 479 
secondary antibody (polyclonal, 2 mg/mL), donkey anti-goat Alexa Fluor® IgG-488 secondary 480 
antibody (polyclonal, 2 mg/mL), donkey anti-rabbit Alexa Fluor® IgG-546 secondary antibody 481 
(polyclonal, 2 mg/mL) and TRIS-HCl were ordered from Life Technologies Invitrogen™.  482 
 483 
In Vitro Characterization of Cellular Responses to Degradable Elastomers 484 
Sample preparation and cell culture: Samples for cell culture studies (n=5) were prepared by spin 485 
coating a solution of 0.4 wt% polymer in CHCl3 on a glass coverslip (1 min. at 1000 rpm). Films were 486 
spin-coated onto silicon wafers and glass coverslips to determine thickness by ellipsometry on a 487 
variable angle spectroscopic ellipsometer (VASE, M-2000 UV− visible−NIR [240−1700 nm] J. A. 488 
Woollam Co., Inc.). Angles used were 55-70 degrees in 5 degree increments, and the Cauchy Layer 489 
model was used to determine sample thickness, with all samples measuring ca. 60 nm. Spin-coated 490 
glass coverslips were then placed into 12 well plates for ethylene oxide (EtO) sterilization, using 0.5 491 
cc/L EtO at room temperature and 35% humidity for 12 hours with an Anprolene benchtop sterilizer 492 
(Anderson Products, Inc., Haw River, NC), followed by a 48 hour purge. 493 
Human Mesenchymal Stem Cells (hMSCs) and MC3T3 fibroblasts were expanded according to 494 
the manufacturer’s protocol and cultured in α-MEM supplemented with 10% FBS and 1% pen/strep 495 
in incubators maintained at 37 °C with 5% CO2. Media was changed every day for the duration of 496 
culture. 497 
 498 
Cell Viability: Cell viability was assessed using a Live/Dead® assay kit. hMSCs (passage 4) and 499 
MC3T3 cells (passage 7) were seeded on spin coated coverslips (n=5) at 4000 cells/cm2. After 24 500 
hours the medium was removed and cells were stained using a Live/Dead® assay kit with 4μM 501 
calcein AM (acetoxymethyl ester) and 2μM ethidium homodimer-1 in PBS, and incubated in the dark 502 
at room temperature for 15 minutes before imaging using an Olympus IX81 inverted fluorescent 503 
microscope equipped with a Hamamatsu Orca R2 fluorescent camera and Olympus CellSens® 504 
Dimension imaging software under TRITC (wavelength = 556/563 nm excitation/emission) and FITC 505 
(wavelength = 490/525 nm excitation/emission) channels to obtain 10 images at 10× magnification of 506 
each specimen. Live and dead cells were counted using NIH ImageJ. The number of live cells was 507 
divided by the total number of cells on each specimen to obtain a percentage of cell viability.  508 
 509 
Cell Proliferation: Cell proliferation of hMSCs seeded on spin-coated glass slides (n=4, 1000 510 
cells/cm2) was evaluated by metabolic activity using a PrestoBlue® Assay following the supplier’s 511 
protocol. Metabolic activity was analyzed at 24 hours, 3 days and 7 days of culture. A standard curve 512 
was prepared by seeding cell suspensions at known concentrations into 12 well plates at least 6 513 
hours before the experiment to allow full attachment. Ten descending concentrations of cells 514 
obtained by serial dilution and one blank were included in the standard curve. After removing the 515 
medium, 1.5 mL of PrestoBlue® solution (10% in cell culture medium) was added to each well, 516 
followed by incubation at 37 °C for 2-4 hours. Sample fluorescence was read when the fluorescence 517 
from the standard curve gave a linear fit. 100 μL of solution was taken from each well and placed in 518 
triplicate into a 96-well plate. The fluorescence intensity (FI) was detected in a BioTek® Synergy™ 519 
MX Microplate Reader at wavelengths of 570 nm for excitation and 615 nm for emission. The 520 
standard curve was fit with a linear relationship by plotting FI vs cell number, with a coefficient of 521 
determination (R2) above 0.99. The cell number was approximated using the obtained equation. 522 
 523 
Cell Seeding onto GRGDS Functionalized Polymer Thin Films: Mouse calvarial stem cells 524 
(MC3T3-E1, Passage 10) were cultured using MEM α (Gibco, Life Technologies) supplied with 10 525 
vol % FBS, 100 units/mL penicillin, and 100 μg/mL streptomycin at 37 oC and 5% CO2. Cells were 526 
subcultured every 3 days with a 0.25% (w/v) trypsin and 0.5% (w/v) EDTA solution. Polymer films 527 
were sterilized by UV irradiation for 15 minutes, washed 3 times with PBS, and soaked with MEM α 528 
for 2 h prior to cell seeding. Cells were seeded onto polymer thin films at 25,000 cells/cm2 (n=4). 529 
 530 
In Vivo Characterization of Tissue Responses to Degradable Elastomers: Elastomer samples 531 
were prepared using vacuum film compression (Technical Machine Products Corporation) to press 532 
0.5 mm thick films at 110 °C under 2,000 lbs of pressure for one hour. PLLA samples were pressed 533 
at 200 °C for ten minutes under 10,000 lbs of pressure, ten minutes under 15,000 lbs of pressure, 534 
and 10 minutes under 20,000 lbs of pressure. Elastomer samples all swelled after compression to be 535 
approximately 1mm thick. PLLA films maintained 0.5mm thickness. After cooling, films were cut into 536 
8 mm diameter discs and placed into 12 well plates for ethylene oxide (EtO) sterilization. Two weeks 537 
prior to surgery, samples were sterilized with a dose of approximately 0.5 cc/L EtO at room 538 
temperature and 35% humidity for 12 hours using an Anprolene benchtop sterilizer (Anderson 539 
Products, Inc.) followed by a 48 hour purge.  540 
 Animals were handled and cared for in accordance with protocols that were approved by the 541 
University of Akron Institutional Animal Care and Use Committee. Female Sprague-Dawley rats 542 
(Harlan Laboratories) aged 60-80 days and weighing approximately 200-224 g were given one week 543 
to acclimate to the facility before performing surgeries. General anesthesia was induced using a 544 
cocktail of ketamine (29.6 mg/kg), xylazine (5.95 mg/kg) and acepromazine (0.53 mg/kg). Prior to 545 
surgery rats were also given 0.02 mg/kg Buprenorphine, which was administered again every 12 546 
hours as needed. The back was shaved and disinfected using several washes with povidone-iodine 547 
solution and sterile alcohol wipes. Four 1 cm incisions were made, each 1 cm away from the spine 548 
with at least 2 cm separating each incision to avoid sample crossover. A subcutaneous pocket was 549 
created using curved hemostats to tunnel into the fascia space anterior to the incision. Each polymer 550 
implant was placed into a pocket, and the incision was closed using Michel clips. An n=6 for each 551 
polymer sample type was implanted per time point, with an n=12 for the PLLA control in order to 552 
have one control sample per rat as direct comparison. The samples were randomized so that 553 
analyses could be performed to check for interactions between samples implanted within the same 554 
animal. Samples were implanted for 1 month, 2 months and 4 months.  555 
 Animals were euthanized using a fatal dose of sodium pentobarbital (0.5 cc per rat) at their 556 
respective time points. A midline incision was made along the spine of the rat and between each 557 
sample. Each sample was isolated, exposed, and photographed to observe macroscopic 558 
inflammation before being removed and fixed in 4% paraformaldehyde overnight. After fixation 559 
samples were rinsed for 15 minutes in distilled water three times, followed by three 15-minute rinses 560 
in 70% ethanol. Samples were then processed into wax overnight using a tissue processor (Leica 561 
ASP300 S, Leica Biosystems) before embedding in paraffin wax for sectioning. 562 
 563 
Histology staining and imaging: Sections (8 to 14 μm thick) were stained for brightfield imaging 564 
with hematoxylin and eosin (H&E), and modified Masson’s trichrome. All images were taken with a 565 
VS120-S6-W automated microscope equipped with both a CCD color camera and a fluorescence 566 
Hamamatsu Orca-Flash4.0 fluorescence camera using DAPI (ex/em = 350/470 nm), FITC (ex/em = 567 
490/525 nm) and TRITC (ex/em = 556/563 nm) filters. Brightfield images were analyzed for 568 
inflammatory markers including granuloma thickness, and qualitatively assessed for general 569 
inflammation compared to PLLA control samples.  H&E slides were also analyzed under 400X light 570 
microscopy for a number of inflammatory cells by a board-certified veterinary pathologist utilizing a 571 
modified scoring system designed by the International Organization for Standardization (ISO 10993-572 
6 Annex E).  Scoring was based on a scale from 0-4 (0 = none; 1 = Rare, 1-5 Minimal; 2 = 5-10, 573 
Mild; 3 = Heavy Infiltrate, Moderate; 4 = Packed, Severe).  The Macrophage analysis from 574 
immunofluorescent images included qualitative assessment of cells located within the inflammatory 575 
region surrounding the implants where CD68 was a positive indicator of a macrophage, CCR7 576 
indicated primarily M1 expression, and CD206 indicated M2 expression.  Samples that showed 577 
tissue infiltration into the polymer space were stained with picrosirius red to observe collagen 578 
deposition and orientation. Images were taken using an Olympus IX70 microscope equipped with a 579 
camera at 40× magnification under brightfield and polarized light conditions using Olympus 580 
MicroSuite™ imaging software. 581 
 582 
Swelling Tests  583 
A film (0.5 mm thickness) of each elastomer was prepared from vacuum film compression using the 584 
same method as stated above. Discs (4 mm) were cut from the film and placed in 1X PBS in the 585 
incubator (37 C, 5% CO2 humidified atmosphere) for up to 32 days. The swelling behavior of the 586 
elastomers were determined by tracking the wet and dry mass of the disc samples (n=3) at each 587 
time point.   588 
 589 
STATISTICS 590 
Results are reported as mean ± standard deviation. One-way analysis of variance (ANOVA) with 591 
Tukey’s post-hoc was performed with a 95% confidence 592 
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Figure 1. Stereocontrolled synthesis and characterization of the resorbable elastomers. (A) A 718 
one-pot thiol-yne step-growth polymerization of propane-1,3-diyl dipropiolate (C3A, 1) with bis(3-719 
mercaptopropyl) succinate (2) and with 1,6-hexane dithiol (C6S) forms a copolymer that shows 720 
tunable degradation rates depending on the % of amount of repeat unit x (1 + 2) that is incorporated. 721 
(B) The stereochemistry is easily determined by the vinyl proton doublets at δ = 5.7 and 7.7 ppm 722 
(trans, 15 Hz) and δ = 5.8 and 7.1 ppm (cis, 9 Hz), respectively. The extent of succinate 723 
incorporation will determine both the rate and extent of degradation. 724 
 725 
Figure 2. Compositional-dependent mechanical properties of the resorbable polymers (A) 726 
Mass loss as a function bis(3-mercaptopropyl) succinate (2) stoichiometry over time in a series of 727 
high cis (78-79%) elastomers show compositionally dependent linear surface erosion behavior. (B) 728 
Increasing the amount of bis(3-mercaptopropyl) succinate (2) which is a longer, bulkier comonomer 729 
reduced the UTS of the resulting elastomers. Mechanical properties and degradation rates are highly 730 
tunable depending on the amount of cis-alkene bonds in the backbone and stoichiometric control of 731 
succinate content. Succinate groups in the chemical structure provide flexibility and hydrophilicity to 732 
the polymer chains and facilitate the degradation process. The increase in chain mobility and 733 
hydrophilicity results in an increase of the number of degradable ester groups and hence the 734 
degradation rates (C) and a decrease of Young’s modulus (D). Increasing the cis-alkene content 735 
resulted in slower degradation rates and higher Young’s moduli values, decreased ultimate strain. 736 
Error bars represent one standard deviation of the mean (n=3).   737 
 738 
Figure 3. Surface Erosion and Swelling (A) Discs (4 mm, 0.5mm thick) were cut from vacuum film 739 
compression samples and placed in 1X PBS in the incubator (37 ⁰C, 5% CO2 humidified 740 
atmosphere) for up to 32 days. The data was plotted in three different ways: dry mass change 741 
compared to the original mass (degradation), wet mass change compared to the original 742 
mas (traditional swelling if no degradation) and wet mass/dry mass at each time point (swelling if 743 
degradation). The swelling behavior of the polymers were determined by tracking the wet and dry 744 
mass of the disc samples at each time point. Error bars represent one standard deviation of the 745 
mean (n=4) (B) Analysis of SEM micrographs of the respective test coupons exposed to accelerated 746 
degradation conditions indicates uniform degradation and pitting indicative of surface erosion 747 
processes. Scale bars = 10 μm.  748 
 749 
Figure 4. Cell Viability and Post polymerization Functionalization. A) Live/Dead® staining of 750 
cells incubated on each substrate for 24 hours. Calcein-AM was used to stain live cells (green) and 751 
ethidium homodimer-1 was used for dead cells (red). Scale Bars are 200 μm. B) Representative 752 
fluorescence pictures of hMSCs cultured on degradable polymer substrates for 72 h. Scale bars are 753 
200 μm. C) Quantitative cell viability data showed >95% viability after 24 hours in both hMSCs and 754 
MC3T3 fibroblasts. Error bars represent one standard deviation of the mean (n=5).  D) Cell 755 
metabolic activity showed an increase in approximate cell number on degradable polymer substrates 756 
over 7 days. Error bars represent one standard deviation of the mean (n=5).  E) To demonstrate the 757 
ability to derivatize the polymers post polymerization, a Megastokes®-673-azide dye surrogate 758 
specifically binds to the internal alkyne functionalized polymer F). Scale bar is 500 μm. Cell 759 
spreading on (poly(bis(4-(propioloyloxy)but-2-yn-1-yl)-3,3'-(hexane-1,6-diylbis(sulfanediyl)))) films 760 
without (G) and with (H) RGD functionalization.   Increased cell adhesion, spreading and integrin-761 
associated actin fiber formation was evident in the RGD derivatized films, indicating that RGD 762 
conjugation was successful. Scale bars are 100 μm. 763 
 764 
Figure 5. Subcutaneous in vivo degradation of Poly(L-lactic acid) (PLLA), 80% cis / 50% succinate 765 
and 80% cis / 100% succinate over a 4-month timeframe. Surgical procedures with subcutaneous 766 
implantation involved a small incision, polymer disc insertion, and incision closure with Michel-clips.  767 
Four samples were implanted per animal (A). (B) Following extraction, the implants can be 768 
visualized in the host tissue using Hematoxylin and Eosin (H&E) and Masson’s Trichrome staining.  769 
As seen, there are almost no macroscopic indications of an inflammatory response.  Whole-mount 770 
cross-section images showing thick fibrous encapsulation surrounding PLLA after 4 months of 771 
incubation in vivo are observed. Similar behavior to PLLA is observed for 80% cis / 50% succinate at 772 
1- and 4-months implantation. Alternatively, the early stages of cellular infiltration are noticed in 80% 773 
cis / 100% succinate after only 1 month (I). After 2- (Supplementary Figure 23) and 4- months, 774 
noticeable shrinking/resorption of the polymer was seen with continued cellular infiltration. 775 
Degradation after 4 months is nearly complete with cells, deposited collagen and tissue fully 776 
encompassing the polymer area. Blood vessel sprouts and multinucleated giant cells are noticeable 777 
throughout the polymer space that has been resorbed. Trichome images show collagen deposition 778 
and immunohistochemistry staining macrophages for pro-inflammatory (M1), non-activated (M0) and 779 
anti-inflammatory (M2) macrophages show degradation induced inflammation and remodeling. Inset 780 
scale bar = 200 μm. Shown micrographs are representative of histology specimens (n=4) from each 781 
of six independent implants (n=6) for each material. 782 
 783 
Figure 6. Picrosirius Red staining of 80cis:100suc elastomers after 1 month and 4 months of 784 
subcutaneous incubation. Collagen deposition and maturation occurred throughout the polymer 785 
space with different orientations representing both mature and developing collagen through the 786 
center of the polymer area. Scale bars are 100 μm. Shown micrographs are representative of 787 





















a An excess of the dialkyne monomer was used to reduce any disulfide coupling and UV crosslinking side reactions 809 
b Determined by comparison of 1H NMR integration of cis peaks at 7.10 ppm and trans peaks at 7.70 ppm 810 









Entry % feed of 2 % incorporation Monomer ratioa Solvent Base 
Time 
(h) % cis
b Mn (kDa) 
Mw 
(kDa) ÐM 
1 0 0 0.9965 CHCl3 DBU 1 80 26.4 147.5 5.60 
2 9.0 9.0 0.9920 CHCl3 DBU 1 80 29.7 111.2 3.74 
3 19.9 18.7 0.9922 CHCl3 DBU 1 79 35.2 110.8 3.15 
4 50.5 49.4 0.9895 CHCl3 DBU 1 79 52.5 123.7 2.36 
5 100 100 0.9870 CHCl3 DBU 1 79 35.9 112.2 3.12 
6 19.8 19.0 0.9920 DMF Et3N 16 72 43.0 127.3 2.96 
7 0 0 0.9920 CHCl3/DMF (7:3) Et3N 16 62 37.0 110.8 3.00 
8 11.2 8.7 0.9959 CHCl3/DMF (7:3) Et3N 16 62 34.2 117.1 3.42 
9 19.6 18.3 0.9920 CHCl3/DMF (7:3) Et3N 16 61 35.3 107.8 3.05 
10c 0 0 0.9950 CHCl3 DBU 1 80 24.7 35.4 1.46 
Table 2. SEC, thermal and mechanical characterization of the degradable elastomers synthesized by step-growth polymerization 820 
incorporating 2. 821 
 822 
a Determined by comparison of 1H NMR spectroscopy integration of cis peaks at 5.8 ppm and 7.1 ppm and trans peaks at 5.7 ppm and 7.7 823 









% cisa % incorporation of 2 Mn (kDa) 
Mw 




(%) UTS (MPa) 
80 9.0 29.7 111.2 3.74 1.7 71.4 33.1 ± 3.3 1457 ± 312 34.9 ± 8.7 
79 18.7 35.2 110.8 3.15 -0.7 50.0 21.1 ± 0.7 1750 ± 163 30.1 ± 5.5 
79 49.4 52.5 123.7 2.36 -0.6 - 2.2 ± 0.4 2161 ± 158 18.9 ± 3.1 
78 58.4 57.8 155.6 2.69 -2.7 - 1.8 ± 0.4 3154 ± 330 14.6 ± 1.3 
78 79.1 29.2 132.7 4.55 -2.3 - 1.9 ± 0.2 2805 ± 149 10.9 ± 0.3 
79 100 35.9 112.2 3.12 -5.1 - 1.6 ± 0.2 2245 ± 1135 0.8 ± 0.4 
62 8.7 34.2 117.1 3.42 -8.1 - 2.1 ± 0.3 1088 ± 320 8.9 ± 3.5 
80 9.0 29.7 111.2 3.74 1.7 71.4 33.1 ± 3.3 1457 ± 312 34.9 ± 8.7 
79 49.4 52.5 123.7 2.36 -0.6 - 2.2 ± 0.4 2161 ± 158 18.9 ± 3.1 
72 19.0 43.0 127.3 2.96 -0.2 49.4 3.2 ± 0.7 2158 ± 247 17.6 ± 3.9 
Table 3. Modified 10993-6 Inflammatory histological Response Analysis  833 
 834 
  835 
Cell Type 
Response 






















Month 4 Month 
Neutrophils 0.3±0.5 0.6±0.9 0.2±0.4 0.1±0.3 0.6±0.7 0.2±0.4 0.1±0.2 0.7±0.9 0.1±0.2 0.4±0.5 0.9±1.0 0.3±0.5 0.4±0.5 1.1±0.6 0.1±0.2 
Lymphocytes 2.5±0.6 2.0±0.7 2.2±0.7 2.8±0.5 2.2±0.7 2.2±0.8 2.7±0.5 2.4±0.8 2.0±0.6 3.7±0.4 1.8±0.8 1.9±0.8 3.7±0.4 2.8±0.7 3.2±0.7 
Plasma Cells 0.1±0.2 0.1±0.3 0±0 0.1±0.2 0.1±0.2 0±0 0±0 0±0 0.1±0.2 0.6±0.6 0.3±0.4 0±0 0.6±0.6 0±0 1.4±0.6 
Single 
Macrophages 1.9±1.2 0±0 1.5±1.4 1.6±1.3 1.0±0.9 1.1±1.2 1.6±1.1 1.2±0.9 0.5±0.8 2.9±0.2 1.7±1.1 0.5±0.9 2.9±0.2 1.4±1.0 3.8±0.4 
Multinucleated 
Giant Cells 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0.9±0.5 0.1±0.2 0±0 0.9±0.5 0.1±0.2 2.5±0.9 
Necrosis 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 
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